Cormorant Private Healthcare Fund III LP, 10% Owner at Ambrx Biopharma Inc. (AMAM), bought 1,000,000 shares at $10.15 ($10.2M) on 2023-03-16, disclosed to the SEC on 2023-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.95 | 250,000 | $2.5M | 24.4% |
| 2 | $10.60 | 250,000 | $2.6M | 25.9% |
| 3 | $10.15 | 500,000 | $5.1M | 49.7% |
| Total | $10.21 avg | 1,000,000 | $10.2M | 100% |
| Filing → |
| AMAM | BUY | 2023-04-17 | $50.6M | — | Filing → |